Product NDC: | 62032-122 |
Proprietary Name: | OBAGI C RX SYSTEM C CLARIFYING SERUM |
Non Proprietary Name: | HYDROQUINONE |
Active Ingredient(s): | 40 mg/mL & nbsp; HYDROQUINONE |
Administration Route(s): | TOPICAL |
Dosage Form(s): | LIQUID |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 62032-122 |
Labeler Name: | OMP, INC. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | |
Marketing Category: | UNAPPROVED DRUG OTHER |
Start Marketing Date: | 20100101 |
Package NDC: | 62032-122-10 |
Package Description: | 1 BOTTLE, GLASS in 1 CARTON (62032-122-10) > 30 mL in 1 BOTTLE, GLASS |
NDC Code | 62032-122-10 |
Proprietary Name | OBAGI C RX SYSTEM C CLARIFYING SERUM |
Package Description | 1 BOTTLE, GLASS in 1 CARTON (62032-122-10) > 30 mL in 1 BOTTLE, GLASS |
Product NDC | 62032-122 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | HYDROQUINONE |
Dosage Form Name | LIQUID |
Route Name | TOPICAL |
Start Marketing Date | 20100101 |
Marketing Category Name | UNAPPROVED DRUG OTHER |
Labeler Name | OMP, INC. |
Substance Name | HYDROQUINONE |
Strength Number | 40 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Depigmenting Activity [PE],Melanin Synthesis Inhibitor [EPC],Melanin Synthesis Inhibitors [MoA] |